MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Press Releases: rheumatoid arthritis

Study Suggests Adalimumab Exposure in Pregnancy Does Not Increase Birth Defects Risk

602 Pregnancies Examined by the Non-Profit Organization of Teratology Information Specialists LA JOLLA, CA –A new study conducted by birth defects experts from the Organization of Teratology Information Specialists (OTIS) suggests adalimumab use in pregnancy was not associated with an increased risk for adverse outcomes examined, such as major structural birth defects, spontaneous abortion and preterm delivery. The findings were published today in the Public Library of Science (PLOS) One …

Read More...

Let’s Stay in Touch

Our e-Newsletter brings you the latest information, news, and resources from the experts at MotherToBaby.

Sign Up Now

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.